AVO announces further delays to LIGHT system

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has attributed delays to the roll-out of its next generation proton beam therapy system LIGHT to unexpected additional requests from regulators. The company, which had been due to go live with the 230MeV beam system by the end of last year, said it was now working to a revised time scale of…

You must be a HM Subscriber to view this content.

Subscribe Now »